Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Exploring Screening and Real-World Use of Teplizumab: Practical Insights and Clinical Experiences
Experts on type 1 diabetes discuss the availability of local medical facilities that offer teplizumab screening and evaluation services for individuals at risk of progression of disease.
EP: 1.Navigating T1D: Mitigating Burden and Monitoring Disease Progression
EP: 2.T1D Staging: The Clinical Importance of Early Recognition
EP: 3.Engaging the Audience: Polling on Primary Populations and Community Perspectives in T1D Care
EP: 4.T1D Antibody Screening: Identifying High-Risk Populations
EP: 5.Role of Teplizumab: First Approved Treatment for Delaying T1D Stage Progression
EP: 6.TN-10 Study Analysis: Expert Perspectives on Key Efficacy and Safety Data
Now Viewing
EP: 7.Exploring Screening and Real-World Use of Teplizumab: Practical Insights and Clinical Experiences
EP: 8.Teplizumab Infusion Protocol: Details on the 14-Day Process and Comprehensive Monitoring Overview
EP: 9.Expert Opinions into the Range of Teplizumab Infusion Locations, Insurance Coverage Hurdles, and the Approval Process
EP: 10.Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab
Recent Videos
Related Content
Man With Newly Diagnosed Type 2 Diabetes: What HbA1c Goal-And How to Get There?
May 8th 2013Podcast
The patient, an active 49-year-old man, had an HbA1c of 8.6 after diabetes was first diagnosed. It’s now 7.6 with metformin and lifestyle measures. Is the current A1c goal adequate, or should you treat more aggressively?
